Provided by Tiger Trade Technology Pte. Ltd.

Beyond Air, Inc.

1.15
+0.105010.05%
Post-market: 1.12-0.0300-2.61%19:48 EST
Volume:333.52K
Turnover:372.37K
Market Cap:12.11M
PE:-0.16
High:1.15
Open:1.08
Low:1.06
Close:1.05
52wk High:10.40
52wk Low:0.6733
Shares:10.53M
Float Shares:9.16M
Volume Ratio:1.13
T/O Rate:3.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.2420
EPS(LYR):-13.7727
ROE:-178.02%
ROA:-49.72%
PB:0.95
PE(LYR):-0.08

Loading ...

Analysts’ Top Healthcare Picks: Beyond Air (XAIR), Molina Healthcare (MOH)

TIPRANKS
·
Feb 06

Beyond Air-Tochter Beyond Cancer präsentiert Phase-1-Daten zu UNO-Therapie auf AACR 2026

Reuters
·
Feb 04

Beyond Air files to sell 7.86M shares of common stock for holders

TIPRANKS
·
Jan 31

XTL Biopharmaceuticals Moves to Acquire 85% Stake in NeuroNOS Ltd

Reuters
·
Jan 30

Beyond Air CEO to Present at Virtual Healthcare Investor Conferences

Reuters
·
Jan 28

Beyond Air Inc. to Announce Third Fiscal Quarter 2026 Financial Results via Conference Call and Webcast

Reuters
·
Jan 27

Beyond Air Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

Beyond Air initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Jan 20

XTL Biopharmaceuticals Acquires 85% Stake in Beyond Air’s NeuroNOS Subsidiary

Reuters
·
Jan 15

Beyond Air Raises $5 Million in Private Placement of Common Stock and Warrants

Reuters
·
Jan 14

Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dow Jones
·
Jan 14

Crude Oil Rises Sharply; US Inflation Rate Holds Steady At 2.7%

Benzinga
·
Jan 14

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR)

TIPRANKS
·
Jan 13

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire
·
Jan 13

XTL Biopharmaceuticals to Acquire NeuroNOS from Beyond Air

Reuters
·
Jan 13

X T L Biopharmaceuticals Ltd: Beyond Air to Receive up to $32.5 Mln in Upfront, Development and Commercial Milestone Payments

THOMSON REUTERS
·
Jan 13

X T L Biopharmaceuticals Ltd: Neuronos Will NOW Serve as Xtl's Flagship Platform for Autism and Neuro-Oncology Therapeutics

THOMSON REUTERS
·
Jan 13

Beyond Air Inc. Files Initial Beneficial Ownership Statement for CFO Daniel Moorhead

Reuters
·
Jan 07

Beyond Air Names Dan Moorhead Chief Financial Officer

Reuters
·
Dec 30, 2025

Beyond Air® Appoints Dan Moorhead as Chief Financial Officer

THOMSON REUTERS
·
Dec 30, 2025